Cereno Scientific has reported initial long-term safety findings from a [...]
As Rare Disease Day 2026 shines a spotlight on patients [...]
Cereno Scientific has completed the last patient’s last visit in [...]
Cereno Scientific has submitted the clinical trial protocol for its [...]
Selection of CRO marks key milestone in advancing CS1 as [...]